Singer D, Sweeney C, Stempniewicz N, Reynolds M, Garbinsky D, Poston S. Knowledge, attitudes, and practices regarding herpes zoster vaccination among specialists. Popul Health Manag. 2024 Aug;27(4):231-40. doi: 10.1089/pop.2023.0284
Ten Eyck L, MacLeod S, Hawkins K, Guimont R, Hartley S. The impact of a heart failure management program in a medicare advantage population. Popul Health Manag. 2019 Apr;22(2):153-61. doi: 10.1089/pop.2018.0072
Bennett KJ, Probst JC, Bullard JC, Crouch E. The importance of rural hospitals: transfers and 30-day readmissions among rural residents and patients presenting at rural hospitals. Popul Health Manag. 2019 Apr;22(2):120-6. doi: 10.1089/pop.2018.0050
MacLeod S, Schwebke K, Hawkins K, Ruiz J, Hoo E, Yeh CS. Need for comprehensive health care quality measures for older adults. Popul Health Manag. 2018 Aug;21(4):296-302. doi: 10.1089/pop.2017.0109
Yosipovitch G, Reaney M, Eckert L, Nelson L, Clark M, Abbe A, Ardeleanu M, Radin A, Gadkari A. Validation of the peak pruritus numerical rating scale: results from clinical studies of dupilumab in adults with moderate-to-severe atopic dermatitis. Poster presented at the Australasian College of Dermatologists 50th Annual Scientific Meeting; May 2017. Sydney, Australia. [abstract] Australas J Dermatol. 2017 May; 58(S1):106-7. Previously presented at the 2017 American Academy of Dermatology Annual Meeting. doi: 10.1111/ajd.21_12652
Rajan SS, Suryavanshi MS, Karanth S, Lairson DR. The immediate impact of the 2009 USPSTF screening guideline change on physician recommendation of a screening mammogram: findings from a national ambulatory and medical care survey-based study. Popul Health Manag. 2017 Apr;20(2):155-64. doi: 10.1089/pop.2015.0180.
Spelman LJ, Lebwohl M, Mordin M, Mallya UG, Gnanasakthy A, Fox T. Secukinumab treatment provides fast relief from patient-reported psoriasis burden. Poster presented at the 48th Australasian College of Dermatologists Annual Scientific Meeting; May 2015. Adelaide, Australia. [abstract] Australas J Dermatol. 2015 May; 56(Suppl 2):73.
Foley P, Sherif B, Mallya UG, Fox T, Gottlieb AB. Secukinumab treatment sustains patient-reported outcome benefits through 1 year. Poster presented at the 48th Australasian College of Dermatologists Annual Scientific Meeting; May 2015. Adelaide, Australia. [abstract] Australas J Dermatol. 2015 May; 56(Suppl 2):56.
Sinclair R, McLeod L, Mallya UG, Fox T, Strober B. Psoriasis patients with PASI90 response achieve greater health-related quality of life improvements than those with PASI75 response. Poster presented at the 48th Australasian College of Dermatologists Annual Scientific Meeting; May 2015. Adelaide, Australia. [abstract] Australas J Dermatol. 2015 May; 56(S2):68.
Mehta H, Patel J, Parikh RC, Abughosh S. Differences in obesity management among physicians. Popul Health Manag. 2012 Oct;15(5):287-92.